FDA takes a closer look at possible cancer risks of widely used blood pressure medicines | NJ.com
Links shared publicly online about this topic.
- 1,018total visits
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines | NJ.com
nj.com —
The agency said it began a review of a class of drugs known as angiotensin receptor blockers after a recently published study suggested the medicines could be associated with a slight increased risk of cancer. The class of drugs includes some of the top-selling blood pressure drugs, such as Merck’s Cozaar and Avapro, a drug marketed by Bristol-Myers Squibb.
View full resource at nj.com
Tags: Heart Disease, High Blood Pressure, High Blood Pressure Medication, Cancer, Drug, FDA, Cozaar, Avapro
Most Recently Shared on July 16, 2010 at 1:51 pm By:
RT @cafepharma: FDA takes closer look at possble cancer risks of popular hypertension meds- Star Ledger, NJ Fri, 07/... http://is.gd/duiBH
Advertisement
